Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Wegovy side effects do improve as the body adjusts to semaglutide. The nausea, loose stools or fatigue that show up in the first few weeks tend to ease once your system settles at a given dose — and they often return briefly with each increase, then settle again. That pattern is well-documented in trial data and in everyday clinical experience. Wegovy is a prescription-only medicine, so a GPhC-registered prescriber reviews your health and circumstances before it is supplied, and side-effect management is part of that ongoing clinical relationship, not an afterthought.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows the rate at which the stomach empties, and it acts on receptors in the gut as well as the brain. When you first introduce that signal, or turn it up with a dose increase, your digestive system needs time to recalibrate. That is why nausea, queasiness, burping and loose stools cluster around the early weeks of each dose level rather than persisting at the same intensity throughout treatment.
The NHS medicines page for semaglutide describes these gastrointestinal effects as common and notes they are generally temporary. In the STEP 1 clinical trial, most GI events were recorded as mild to moderate and a substantial proportion resolved without any change in treatment. The escalation schedule (moving up slowly through doses over several months) was designed with exactly this in mind.
One misconception worth putting to rest: some people assume persistent nausea means the medicine is not working, or that feeling better means it has stopped working. Neither is true. As your body adapts, the signalling becomes quieter while the appetite-regulating effect continues. If you want to understand how soon you are likely to get side effects from Wegovy, the timing follows a fairly consistent pattern that is worth knowing in advance, and so does the question of how soon after taking Wegovy you are likely to get side effects.
The effects most likely to ease with time are the gastrointestinal ones: nausea, vomiting, diarrhoea, constipation, indigestion, stomach discomfort and burping. For most people these are sharpest in the first week or two at a new dose and meaningfully better by week three or four. Fatigue and headache, which some people notice early on, also tend to be transient.
Diarrhoea is worth mentioning separately. It is one of the effects people find most disruptive but, for the majority, it is tied to the adjustment period. There is a fuller explanation of why diarrhoea happens on Wegovy and what helps if that is the symptom you are most concerned about.
Injection-site reactions (redness, itching or mild swelling) usually resolve on their own and rotating injection sites reduces the chances of them recurring. A small number of people experience ongoing nausea at higher doses; in those cases, a prescriber may recommend staying at the current dose for longer before increasing, or consider whether the highest dose is the right target for that individual. Side effects that persist beyond a few weeks at a stable dose are worth discussing with your clinical team rather than simply enduring. You can read more about the full range of Wegovy side effects and their relative frequency.
Not every symptom is one to manage at home. Some require prompt attention, and knowing which is which matters.
Seek urgent medical help if you develop severe, persistent stomach pain, especially if it spreads to your back, with or without vomiting. This can be a sign of pancreatitis, a serious but infrequent side effect. In January 2026 the MHRA issued a Drug Safety Update specifically reminding prescribers and patients that acute pancreatitis has been reported with GLP-1 medicines and should be treated as a medical emergency, not a side effect to sit out.
Other situations that warrant prompt contact with a healthcare professional include: signs of a serious allergic reaction (swelling of the face, lips, throat or tongue; difficulty breathing; a rapid heartbeat); symptoms of severe dehydration from prolonged vomiting or diarrhoea (feeling faint, producing very little urine, confusion); and gallbladder symptoms such as sudden sharp pain in the upper right abdomen. Low mood or thoughts of self-harm should prompt immediate contact with a doctor or a crisis service.
For anything you are unsure about, you can also report a suspected side effect (or flag a medicine you are uncertain about) through the MHRA's Yellow Card scheme. The scheme exists for patients as well as clinicians, and your report contributes to ongoing safety monitoring of these medicines.
Some people start Wegovy, a once-weekly injectable treatment for weight management, and feel almost nothing different beyond a quieter appetite. This sometimes causes its own anxiety, a suspicion that the medicine is not doing anything, or that the pen was faulty. The reality is that individual responses vary considerably, and an absence of side effects is not a warning sign. The experience of having no side effects on Wegovy is more common than many people expect and does not predict whether the treatment will be effective for you.
What does matter, in every case, is that treatment is reviewed by someone who knows your history. Our prescribers at nume discuss side-effect management and suitability as part of every consultation, before treatment starts and before each repeat. If you are considering Wegovy and want to talk through what to expect for your particular situation, checking your eligibility takes a few minutes and is entirely free.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.